Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity.
about
Oncolytic viruses as therapeutic cancer vaccinesPurinergic signalling and cancerA novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell deathOncolytic viruses as immunotherapy: progress and remaining challengesRadio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical ApplicationsA sequence-specific DNA binding small molecule triggers the release of immunogenic signals and phagocytosis in a model of B-cell lymphomaConcepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapiesPrognostic and Predictive Value of DAMPs and DAMP-Associated Processes in CancerCD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growthMechanisms of chemotherapy-induced behavioral toxicitiesWhat future opportunities may immuno-oncology provide for improving the treatment of patients with lung cancer?Monobenzone-induced depigmentation: from enzymatic blockade to autoimmunityInfluenza virus activates inflammasomes via its intracellular M2 ion channelThe dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunityBeginnings of a good apoptotic meal: the find-me and eat-me signaling pathwaysThe role of nucleotides in apoptotic cell clearance: implications for disease pathogenesis.Clearance of apoptotic cells: implications in health and diseaseSkin-resident T cells sense ultraviolet radiation-induced injury and contribute to DNA repair.Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in miceRole of extracellular nucleotides in the immune response against intracellular bacteria and protozoan parasitesChemoimmunotherapy.Activation of macrophages by P2X7-induced microvesicles from myeloid cells is mediated by phospholipids and is partially dependent on TLR4.Tumor antigen cross-presentation and the dendritic cell: where it all begins?Inflammasome activation is critical to the protective immune response during chemically induced squamous cell carcinoma.Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.Eradication of solid tumors using histone deacetylase inhibitors combined with immune-stimulating antibodies.P2X7 integrates PI3K/AKT and AMPK-PRAS40-mTOR signaling pathways to mediate tumor cell death.Oral bacteria and cancer.Classification of current anticancer immunotherapiesProposed mechanisms of action for prostate cancer vaccines.Protein-bound polysaccharide-K induces IL-1β via TLR2 and NLRP3 inflammasome activation.P2X7 on Mouse T Cells: One Channel, Many FunctionsUnlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacyCancer and innate immune system interactions: translational potentials for cancer immunotherapy.The Cytolytic Amphipathic β(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 MelanomaPast, present, and future of molecular and cellular oncologyTrial watch: Chemotherapy with immunogenic cell death inducersDistinct cathepsins control necrotic cell death mediated by pyroptosis inducers and lysosome-destabilizing agents.Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β.Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner.
P2860
Q21245758-DE11DD37-B96A-4C9E-BA9D-5BCE966BFF2EQ24618782-70A370E2-3D55-460C-85B3-CEEC3427BF16Q24620548-53BE9D2B-E314-4F1C-914A-ED8EFA0E88E9Q26745942-3E4EDCB0-0FB4-45FF-A52D-BE690AAC07ADQ26779221-E5250817-DFDA-4CA2-B68F-E47C4B7DFAC1Q26780141-E3ED0BF6-DDC6-4BD6-AF35-B6B1171B6AEBQ26781215-94138A10-2982-46F8-954D-262390F60EEAQ26795466-59C5A82F-8579-4C47-B41E-1E0CE54A0DC5Q26823709-ACFEF47A-2FDE-48D6-8BFB-8081B039BA0FQ26998870-45B89780-CBBE-484E-B4AD-7E66C51EDF7AQ27012886-2DE51E27-186B-445C-9EBF-2EA529BDDD4BQ28241227-F7A54EAC-DCB3-44F8-B7F8-7D7DDFF8690DQ28279385-A97F5685-9E0F-4E32-BA2A-388DE7E3E763Q28384138-0392A768-6C99-4875-BE54-3635FF4878BAQ30424410-DB55EB00-04B2-4982-ABF8-189209194BA1Q30429149-7BD476B6-28FA-4EE0-A583-B92E0DAD7604Q30433781-E209E003-B6B4-4F56-BD6F-8880D714D4CBQ33723689-A9BBE641-0825-4894-9917-0CD40882D7BAQ33823499-D8DC8786-0CFB-43F6-AFBF-CE7FB8BCA041Q33946436-1F2EC579-33B2-4102-9021-67016C593CBBQ34058792-FB18A967-6E89-4926-8322-7567042C971DQ34103835-A8B4B49C-66CB-4E8D-94AD-75C0E7A735BDQ34210664-689D4CA4-140F-48C5-93B8-24484450E316Q34275796-3DEBF3A1-05E2-4079-B3E6-C0B2F1D3DA80Q34633667-98327BF2-53CC-4B39-A9E0-EC1BD3C99E1CQ34652570-69794068-8942-4CA0-A9C8-79E2912720E3Q34658181-DEB82620-8F7B-4C89-B244-0AB4B75C523BQ35133888-01BB09C2-22A9-4D8B-9217-902F5AEB974DQ35149637-DB4DEED2-F572-4271-AE21-480D98805D3BQ35174754-C9F1728D-BFD8-4E08-9B1C-92457AE0EAE9Q35551792-0FEF9079-7E86-473B-9BB2-D29CDC78D600Q35621886-3BD7D4FF-54C2-44A8-AA31-2BB908E92849Q35657822-22E3B0F5-746E-48EC-B292-F67C1218FEEDQ35902972-D764BEDF-052C-4BDC-805A-B8740967A934Q35924903-49887F0C-7AB0-4164-BA30-8F8C7EE979C0Q35972276-AB0B2E27-05DA-43E2-B429-C5B025C89B3AQ36038456-AF21412F-E0E0-46D6-B467-BCFB1F3C13DEQ36189208-8FE36472-BF14-4F74-A52F-029D363CF347Q36191597-80135FC6-D48A-43AF-BA2C-AA92125E3BCFQ36346964-CF681B26-B9B3-45B1-A958-DDCADB2943E1
P2860
Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity.
@en
Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity.
@nl
type
label
Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity.
@en
Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity.
@nl
prefLabel
Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity.
@en
Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity.
@nl
P50
P1433
P1476
Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity.
@en
P304
P356
10.1158/0008-5472.CAN-09-3566
P407
P50
P577
2010-01-19T00:00:00Z